Have you wondered what happens on a neuro-scientific and
physiological level when phsychedelics enter your body? That
question has been at the root of the psychedelic experience for
generations if not centuries. Ancient mystics had the understnading
that these sacred plant medicines contained tribal DNA which was
necessary to keep cultures and history alive. However, now that we
have more data and research available we can augment that thinking
with actual stuides that illustrate how the brain is effected when
these agents enter our system.
Highlighting the results of two fMRI studies and one MEG study
with psilocybin and an fMRI study with MDMA, Carhart-Harris will
report the effects of both drugs on regional brain activity and
brain network organization. Additionally, he will report the
effects of both drugs on brain and subjective responses to personal
autobiographical memory cues.
Dr Robin Carhart-Harris talks about his scientific research
into the effects and potential therapeutic uses of psychedelic
drugs. Join him as he discusses brain imaging work involving
psilocybin, the active ingredient of magic mushrooms, and explains
how the drug works in the brain.
In 2005, Robin began a four year PhD in Psychopharmacology at
the University of Bristol. In 2009, he successfully coordinated the
first clinical study of psilocybin in the UK and the first clinical
study of a classic psychedelic drug in the UK for over 40 years.
Also in 2009, Robin moved to Imperial College London to continue
his work under the supervision of Professor David Nutt. Robin has
since coordinated the first resting state fMRI and MEG
investigations of a psychedelic drug and the first fMRI study of
MDMA in the UK. Robin and David Nutt recently received ethics
approval for an MRC-sponsored clinical trial that
will investigate the efficacy of psilocybin as a
treatment for depression and an LSD fMRI and MEG study. Robin's
work is published
in PNAS, Brain, Schizophrenia
Bulletin and the British Journal of
Psychiatry and he has appeared in television interviews
for BBC news and Channel 4.
About the Podcast
The intent of the podcast is to bring you the listener an easily accessible resource for a variety of topics all related to psychedelic research. There is a lot to learn about new research into the therapeutic potential of psychedelics and marijuana. Over the years, the Multidisciplinary Association for Psychedelic Studies (MAPS) has amassed an incredible treasure trove of audio archives sourced from the amazing talks, presentations and panels that have taken place at past Psychedelic Science conferences and other unique events. By selecting some of that content and then bringing it to you in a podcast we hope to create a centralized location for the greater MAPS community. If you're a researcher, scientist, medical professional or just a curiosity seeker we hope that you'll find this content a valuable resource tool.
Please visit the MAPS website at https://maps.org